High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer
1996

High Dose Rate Brachytherapy for Oesophageal Cancer

Sample size: 74 publication Evidence: moderate

Author Information

Author(s): BG Taal, BMP Aleman, CCE Koning, H Boot

Primary Institution: Netherlands Cancer Institute/Antoni van Leeuwenhoekhuis

Hypothesis

Can high dose rate brachytherapy before external beam irradiation effectively relieve dysphagia in patients with inoperable oesophageal cancer?

Conclusion

Brachytherapy before external beam radiotherapy is a safe and effective method for quickly relieving dysphagia in patients with inoperable oesophageal cancer.

Supporting Evidence

  • Complete remission was observed in 21 patients and partial response in 38 patients, leading to an overall response rate of 80%.
  • Improvement in dysphagia was noted in 70% of patients by the end of treatment.
  • Median survival for patients was 9 months.

Takeaway

Doctors used a special type of radiation treatment to help people with a hard time swallowing because of cancer, and it worked really well for many of them.

Methodology

Patients received 10 Gy HDR brachytherapy followed by 40 Gy external beam radiotherapy over 4 weeks, with evaluations of symptoms and tumor response.

Potential Biases

Potential understaging of disease due to reliance on non-surgical diagnostic methods.

Limitations

The study had a relatively small sample size and focused on short-term outcomes; long-term survival rates remain poor.

Participant Demographics

74 patients, 70% male, median age 67 years, with squamous cell carcinoma and adenocarcinoma.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication